题名

精神遺傳流行病學幾個方法

并列篇名

Approaches to Psychiatric Genetic Epidemiology

DOI

10.29478/TJP.200609.0002

作者

龍佛衛(For-Wey Lung)

关键词

精神遺傳流行病學 ； 認知功能 ； 人格特質 ； 交互作用 ； psychiatric genetic epidemiology ； cognitive function ； personality characteristics ； interaction

期刊名称

台灣精神醫學

卷期/出版年月

20卷3期（2006 / 09 / 01）

页次

172 - 181

内容语文

繁體中文
中文摘要

精神疾病的危險因子包含生物、藥理、家庭、社會以及環境等層面，而許多家族、孿生子之遺傳研究亦強調遺傳因素的重要性。現今對於精神疾病的研究趨勢逐漸從症狀學轉向生化、認知以及遺傳因素進行探討，且隨著和疾病相關之遺傳知識的不斷累積以及生物科技的日益精進，遺傳流行病學逐漸發展，從遺傳與流行病學的角度來探討精神疾病的致病原因，以發展更有效的治療方式，並冀望在疾病初發之前即能作好事先的預防。本文旨在對於精神遺傳流行病學幾個觀點作一介紹，並藉由一些研究的結果舉例說明，讓讀者對於精神疾病的遺傳基因、認知功能、人格特質等各種遺傳機制有不同的認識，並進一步瞭解遺傳與環境之間的交互作用。
英文摘要

Risk factors for psychiatric disorders include biological, pharmacological, familial, social and environmental dimensions. The importance of genetic vulnerability has been emphasized by many family and twin studies. Recently, the focus of psychiatric research has shown a gradual change from symptomatology to biochemical, cognitive, and genetic factors. The field of psychiatric genetic epidemiology has developed from the accumulation of genetic data and advances in microbiological techniques. Information obtained from psychiatric genetic epidemiology is now showing promise in applications for effective treatment and prevention psychiatric illnesses. The aim of this article is to review the main perspectives of psychiatric genetic epidemiology and to provide several illustrative examples for readers of various genetic diatheses as they relate to cognitive function, personality characteristics, as well as to the interaction of genetic and environmental factors. (Full text in Chinese)
主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Anguelova M,Benkelfat C,Turecki G(2003).A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior.Mol Psychiatry,8,646-653.
  2. Aviv A,Harley CB(2001).How long should telomeres be?.Curr Hypertens Rep,3,145-151.
  3. Bellivier F,Chaste P,Malafosse A(2004).Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis.Am J Med Genet B Neuropsychiatr Genet,124,87-91.
  4. Bondi MW,Monsch AU,Butters N(1993).Utility of a modified version of the Wisconsin Card Sorting Test in the detection of dementia of the Alzheimer type.Clin Neuropsychol,7,161-170.
  5. Bowlby SJ(1977).The making and breaking of affectionate bonds: a etiology and psychopathology in the light of attachment theory.Br J Psychiatry,130,201-210.
  6. Brent DA,Mann JJ(2005).Family genetic studies, suicide, and suicidal behavior.Am J Med Genet C Semin Med Genet,113,13-24.
  7. Brown GL,Ebert MH,Goyer PF(1982).Aggression, sucide and serotonin: relationships to CSF amine metabolites.Am J Psychiatry,139,741-746.
  8. Catts VS,Catts SV(2000).Apoptosis and schizophrenia: is the tumor suppressor gene, p53, a candidate susceptibility gene?.Schizophr Res,41,405-415.
  9. Chang FH,Tzeng DS,Lee TM,Chen TC,Hsu LS,Lung FW(2003).Mutations of p53 tumor suppressor gene in colorectal cancer in Taiwan.Kaohsiung J Med Sci,19,151-158.
  10. Cleare AJ,Bond AJ(1997).Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.Psychiatry Res,9,89-95.
  11. Clementz BA,Grove WM,Iacono WG,Sweeney JA(1992).Smooth-pursuit eye movement dysfunction and liability for schizophrenia: implications for genetic modeling.J Abnorm Psychol,101,117-129.
  12. Coccaro EJ,Siever LJ,Klar HM(1989).Serotonergic studies in patients with affective and personality disorders.Arch Gen Psychiatry,46,587-599.
  13. Eysenck HJ,Eysenck MW(1985).Personality and Individual differences: A Natural Science Approach.New York and London:Plenum Press.
  14. Fan PL,Chen CD,Kao WT,Shu BC,Lung FW(2006).Protective effect of the apo ε2 allele in major depressive disorder in Taiwanese.Acta Psychiatr Scand,113,48-53.
  15. Fan PL,Hsing SC,Shiang JC,Kuo TS,Lung FW(2006).Hypertension-a possible vulnerability marker for depression in patients with end-stage renal disease.Nephron Clin Pract,102,43-50.
  16. Faraone SV,Tsuang MT,Tsuang DW(1999).Genetics of Mental Disorders: What Practitioners and Students Need to Know.New York:The Guilford Press.
  17. Figueiredo IV,Martinez Coscolla A,Caramona MM,Callingham BA(1998).Monoamine oxidase activities in human cystic and colonic arteries-influence of age.J Neural Transm Suppl,52,217-223.
  18. Gabryelewicz T,Religa D,Styczynska M(2002).Behavioural pathology in Alzheimer`s disease with special reference to apolipoprotein E genotype.Dement Geriatr Cogn Disord,14,208-212.
  19. Green RC,Cupples LA,Kurz A(2003).Depression as a risk factor for Alzheimer`s disease: the MIRAGE Study.Arch Neurol,60,753-759.
  20. Grove WM,Clementz BA,Iacono WG,Katsanis J(1992).Smooth pursuit ocular motor dysfunction in schizophrenia: evidence for a major gene.American Psychiatric Association,149,1362-1368.
  21. Hagerman RJ,Silverman AC(1991).Fragile X Syndrome: Diagnosis, Treatment, and Research.Baltimore:John Hopkins University Press.
  22. Holzman PS,Solomon CM,Levin S,Waternaux CS(1984).Pursuit eye movement dysfunctions in schizophrenia.Arch Gen Psychiatry,41,136-139.
  23. Hunter DJ(2005).Gene-environment interactions in human diseases.Nat Rev Genet,6,287-298.
  24. Joynt EK,Whellan DJ,O`Connor CM(2003).Depression and cardiovascular disease: mechanisms of interaction.Soc Biol Psychiatry,54,248-261.
  25. Kawajiri K,Nakachi K,Imai K,Watanabe J,Hayashi S(1993).Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer.Carcinogenesis,14,1085-1089.
  26. Kimmel PL,Thamer M,Richard CM,Ray NP(1998).Psychiatric illness in patients with end-stage renal disease.Am J Med,105,214-221.
  27. Kirchgessner CU,Warren ST,Willard HF(1995).X inactivation of FMR1 fragile X mental retardation.J Med Genet,32,925-929.
  28. Koenig HG,Blazer DG(1992).Epidemiology of geriatric affective disorders.Clin Geriatr Med,8,235-252.
  29. Lavretsky H,Ercoli L,Siddarth P,Bookheimer S,Miller K,Small G(2003).Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.Am J Geriatr Psychiatry,11,667-673.
  30. Lawrence V,Houghton S,Douglas G,Durkin K,Whiting K,Tannock R(2004).Executive function and ADHD: a comparison of children`s performance during neuropsychological testing and real-world activities.J Atten Disord,7,137-149.
  31. Levine AJ(1997).p53, the cellular gatekeeper for growth and division.Cell,88,323-331.
  32. Levy DL,Holzman PS,Matthysse S,Mendell NR(1993).Eye tracking dysfunction and schizophrenia: a critical perspective.Schizophr Bull,19,461-535.
  33. Lichtermann D,Ekelund J,Pukkala E,Tanskanen A,Lonnqvist J(2001).Incidence of cancer among persons with schizophrenia and their relatives.Arch Gen Psychiatry,58,573-578.
  34. Liebert RM,Liebert LL(1998).Liebert & Spiegler`s Personality Strategies and Issues.California:Brooks & Corle.
  35. Lin HY,Huang CH,Wu WJ,Chou YH,Fan PL,Lung FW(2005).Mutation of the p53 tumor suppressor gene in transitional cell carcinoma of the urinary tract in Taiwan.Kaohsiung J Med Sci,21,57-64.
  36. Lin PY,Tsai G(2004).Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis.Boil Psychiatry,55,1023-1030.
  37. Liu CY,Hong CJ,Liu TY(2002).Lack of association between the apolipoprotein E genotype and depression in Alzheimer`s disease.J Geriatr Psychiatry Neurol,15,20-23.
  38. Lubs HA(1969).A marker X chromosome.Am J Hum Genet,21,231-244.
  39. Lung FW,Chen N,Shu BC(2006).Dopamine D4 receptor gene and the -521>T poly morphism of the upstream region of the dopamine D4 receptor gene in schizophrenia.Psychiatr Genet,16,139-143.
  40. Lung FW,Fan PL,Chen NC,Shu BC(2005).Telomeric length varies with age and polymorphisms of the MAOA gene promoter in peripheral blood cells obtained from a community in Taiwan.Psychiatr Genet,15,31-35.
  41. Lung FW,Huang YL,Shu BC,Lee FY(2004).Parental rearing style, premorbid personality, mental health, and quality of life in chronic regional pain: a causal analysis.Compr Psychiatry,45,206-212.
  42. Lung FW,Lee FY,Shu BC(2006).The premorbid personality in military students with adjustment disorder.Mil Psychol,18,77-88.
  43. Lung FW,Lee FY,Shu BC(2002).The relationship between life adjustment and parental bonding in military personnel with adjustment disorder in Taiwan.Mil Med,24,67-74.
  44. Lung FW,Lee TM,Shu BC,Chang FH(2004).p53 cod-on 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan.J Cancer Res Clin Oncol,130,728-732.
  45. Lung FW,Lin TJ,Lu YC,Shu BC(2004).Personal characteristics of adolescent prostitutes and rearing attitudes of their parents: a structural equation model.Psychiatry Res,125,285-291.
  46. Lung FW,Lu YC,Wang YC(1999).Relationship between smooth pursuit eye-tracking and Wisconsin Card Sorting Test in schizophrenia.Taiwanese J Psychiatry,13,270-281.
  47. Lung FW,Tzeng DS,Shu BC(2002).Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia.Schizophr Res,57,239-245.
  48. Lung FW,Yen YC,Chou LJ,Hong CJ,Wu CK(2004).The allele interaction between apolipoprotein ε2 and ε4 in Taiwanese Alzheimer`s disease patients.Acta Psychiatr Scand,111,38-43.
  49. Majdan M,Lachance C,Gloster A(1997).Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis.J Neurosci,17,6988-6998.
  50. Manuck SB,Flory JD,Ferrel RE,Mann JJ,Muldoon MF(2000).A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity.Psychiatry Res,95,9-23.
  51. Mauricio M,O`Hara R,Yesavage JA(2000).A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.Am J Geriatr Psychiatry,8,196-200.
  52. McLaughlin T,Geissler EC,Wan GJ(2003).Comorbidities and associated treatment charges in patients with anxiety disorders.Pharmacotherapy,23,1251-1256.
  53. Migliorelli R,Teson A,Sabe L,Petracchi M,Leiguarda R,Starkstein SE(1995).Prevalence and correlates of dysthymia and major depression among patients with Alzheimer`s disease.Am J Psychiatry,152,37-44.
  54. Mortensen PB(1989).The incidence of cancer in schizophrenic patients.J Epidemiol Commun Health,43,43-47.
  55. Morton NE,Chung SC (eds.)(1978).Genetic epidemiology.New York:Academic Press.
  56. Murphy GM,Kremer C,Rodrigues H,Schatzberg AF(2003).Mitrazapine versus paroxetine Study Group: The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.Biol Psychiatry,54,665-673.
  57. Ormel J,Wohlfarth T(1991).How neuroticism, long- term difficulties, and life situation change influence psychological distress: a longitudinal model.J Pers Soc Psychol,60,744-755.
  58. Plomia R,DeFries JC,McClean GE,McGuffin P(2001).Behavioral Genetics.New York:Worth.
  59. Rapp SR,Parisi SA,Walsh DA(1988).Detecting depression in elderly medical inpatients.J Consult Clin Psychol,56,509-513.
  60. Rodgers B(1990).Behaviour and personality in childhood as predictors of adult psychiatric disorder.J Child Psychol Psychiatry,31,393-414.
  61. Rujescu D,Giegling I,Sato T,Hartmann AM,Moller HJ(2003).Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis.Biol Psychiatry,54,465-473.
  62. Sambamurti K,Granholm AC,Kindy MS(2004).Cholesterol and Alzheimer`s disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.Curr Drug Targets,5,517-528.
  63. Saura J,Richards JG,Mahy N(1994).Differential age-related changes of MAOA and MAOB in mouse brain and peripheral organs.Neurobiol Aging,15,399-408.
  64. Shu BC,Lung FW,Tien AY,Chen BC(2001).Executive function deficits in non-retarded autistic children.Autism,5,165-174.
  65. Strolin-Benedetti M,Thomassin J,Tocchetti P,Kettler R,Da Prada M(1994).Species differences in changes of heart monoamine oxidase activities with age.J Neural Transm Suppl,41,83-87.
  66. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo(1997).EMBO J,16,1391-1400.
  67. Walker EF,Savoie T,Davis D(1994).Neuromotor precursors of schizophrenia.Schizophr Bull,20,441-451.
  68. Wang YC,Chen CY,Chen SK,Chang YY,Lin P(1999).p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.Clin Cancer Res,5,129-134.
  69. Warren ST,Nelson DL(1994).Advances in molecular analysis of fragile X syndrome.JAMA,271,536-642.
  70. Watson JD,Crick FHC(1953).Molecular structure of nucleic acids.Nature,171,737-738.
  71. Weston A,Perrin LS,Forrester K(1992).Allelic frequency of a p53 polymorphism in human lung cancer.Cancer Epidemiol Biomarkers Prev,1,481-483.
  72. William FC,Clarine J,Hilleke E,Hugo G,Margriet M(2001).Volumes of brain structures in twins discordant for schizophrenia.Arch Gen Psychiatry,58,33-40.
  73. 龍佛衛、王英郁、呂宜靜、黃淑芬。行政院衛生署93年度補助計畫行政院衛生署93年度補助計畫,未出版
print cancel